Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to <i>Flt3-</i>ITD mutations.

Porter, Shaina N; Cluster, Andrew S; Yang, Wei; Busken, Kelsey A; Patel, Riddhi M; Ryoo, Jiyeon; Magee, Jeffrey A · Elife · 2016

basic_science · Level V

Where this comes from

Abstract

The <i>FLT3</i> Internal Tandem Duplication (<i>FLT3<sup>ITD</sup></i>) mutation is common in adult acute myeloid leukemia (AML) but rare in early childhood AML. It is not clear why this difference occurs. Here we show that <i>Flt3<sup>ITD</sup></i> and cooperating <i>Flt3<sup>ITD</sup>/Runx1</i> mutations cause hematopoietic stem cell depletion and myeloid progenitor expansion during adult but not fetal stages of murine development. In adult progenitors, FLT3<sup>ITD</sup> simultaneously induces self-renewal and myeloid commitment programs via STAT5-dependent and STAT5-independent mechanisms, respectively. While FLT3<sup>ITD</sup> can activate STAT5 signal transduction prior to birth, this signaling does not alter gene expression until hematopoietic progenitors transition from fetal to adult transcriptional states. Cooperative interactions between <i>Flt3<sup>ITD</sup></i> and <i>Runx1</i> mutations are also blunted in fetal/neonatal progenitors. Fetal/neonatal progenitors may therefore be protected from leukemic transformation because they are not competent to express FLT3<sup>ITD</sup> target genes. Changes in the transcriptional states of developing hematopoietic progenitors may generally shape the mutation spectra of human leukemias.

Medical subject headings